Back to Journals » Drug Design, Development and Therapy » Volume 13

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report

Total article views   Abstract views HTML views PDF downloads Totals
1,229 Dovepress* 1,189 40+ 169 1,229
Totals 1,189 40 169 1,229
*Since 11 January 2019
+Since July 2016

View citations on Google Scholar